Posted by Michael Wonder on 15 Sep 2022
FDA’s drug industry fees fuel concerns over influence
15 September 2022 - The pharmaceutical industry finances about 75% of the agency’s drug division, through a controversial program that Congress must reauthorise by the end of this month.
Every five years, top officials of the FDA go behind closed doors to negotiate the terms of its core budget — about $3 billion this year.
